Editorial Ahead of print
PubMed: 41934039 DOI: 10.1016/j.eururo.2026.03.006
Redefining the Landscape of Genitourinary Cancer Precursors: The International Society of Urological Pathology Consensus Recommendations.
Eur Urol
Authors: Liang Cheng, Kenneth A Iczkowski, Geert J L H van Leenders, Michelle R Downes, Maria R Raspollini, Sean R Williamson, Holger Moch, Felix Bremmer, Satish K Tickoo, Santosh Menon, Antonio L Cubilla, Glen Kristiansen
Affiliations
- Department of Pathology and Laboratory Medicine, Department of Surgery (Urology), Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, RI, USA.
- Department of Pathology and Laboratory Medicine, University of California-Davis Health, Sacramento, CA, USA.
- Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Division of Anatomic Pathology, Department of Laboratory Medicine and Molecular Diagnostics, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre; Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
- Histopathology and Molecular Diagnostics, University Hospital Careggi, Florence, Italy.
- Department of Pathology, Diagnostics Institute, Cleveland Clinic, Cleveland, OH, USA.
- Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
- Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany.
- Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Department of Pathology, Tata Memorial Centre and Homi Bhabha National Institute, Mumbai, Maharashtra, India.
- Instituto de PatologÃa e Investigación, Asunción, Paraguay and Universidad Nacional de Asunción, San Lorenzo, Paraguay.
- Institute of Pathology, University Hospital Bonn, Bonn, Germany.
Abstract
The International Society of Urological Pathology Florence Multidisciplinary Consensus Conference establishes a contemporary framework for the definition and standardized reporting of genitourinary cancer precursor lesions. These consensus recommendations provide evidence-based guidance for diagnostic practice, inform clinical management, and define priorities for future research in genitourinary premalignancy.
MeSH
Urogenital Neoplasms, Neoplasms, Pathology